Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MEIP

MEI Pharma (MEIP) Stock Price, News & Analysis

MEI Pharma logo

About MEI Pharma Stock (NASDAQ:MEIP)

Key Stats

Today's Range
N/A
50-Day Range
$2.78
$5.28
52-Week Range
N/A
Volume
3.98 million shs
Average Volume
1.15 million shs
Market Capitalization
$104.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MEI Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
10th Percentile Overall Score

MEIP MarketRank™: 

MEI Pharma scored higher than 10% of companies evaluated by MarketBeat, and ranked 911th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for MEI Pharma.

  • Earnings Growth

    Earnings for MEI Pharma are expected to grow in the coming year, from ($5.10) to ($3.71) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MEI Pharma is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MEI Pharma is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for MEIP.
  • Dividend Yield

    MEI Pharma does not currently pay a dividend.

  • Dividend Growth

    MEI Pharma does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MEIP.
  • MarketBeat Follows

    1 people have added MEI Pharma to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MEI Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.12% of the stock of MEI Pharma is held by insiders.

  • Percentage Held by Institutions

    52.38% of the stock of MEI Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MEI Pharma's insider trading history.
Receive MEIP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MEIP Stock News Headlines

MEI Pharma to change name to Lite Strategy
Options Pro Reveals His #1 Retirement Income Trade
If you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading strategy that could help accelerate your retirement goals. It’s called the Retirement Trade — a short-term approach designed to capture consistent morning setups without waiting months for results.tc pixel
MEI Pharma Welcomes New Board Member Joshua Riezman
MEI Pharma’s Strategic Shift with Litecoin Treasury
See More Headlines

MEIP Stock Analysis - Frequently Asked Questions

MEI Pharma, Inc. (NASDAQ:MEIP) issued its earnings results on Tuesday, May, 13th. The company reported ($0.39) earnings per share (EPS) for the quarter.

MEI Pharma's stock reverse split on the morning of Monday, April 17th 2023.The 1-20 reverse split was announced on Monday, April 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that MEI Pharma investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), CymaBay Therapeutics (CBAY) and Jabil (JBL).

Company Calendar

Last Earnings
5/13/2025
Today
10/15/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MEIP
Previous Symbol
NASDAQ:MSHL
CIK
1262104
Employees
100
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
($4.75)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$17.78 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-77.00%
Return on Assets
-64.79%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
16.78
Quick Ratio
16.78

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
0.51
Book Value
$4.96 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
32,838,000
Free Float
31,813,000
Market Cap
$104.72 million
Optionable
Optionable
Beta
0.38

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:MEIP) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners